Histamine H4 receptor Research

Cost Action BMO806
Histamine H4 receptor Research
HARR4-Eu COST

WG4 - Therapeutic potential of the H4R and the new compounds

Austria

Leader

Prof. Dr. Holger Stark

Johann Wolfgang Goethe
University Institute of Pharmaceutical,
Chemistry Biocentrum,
Building N240 Room 3.03a
Max-von Laue-Str. 9
60438 Frankfurt am Main
Germany

+49-69-798 29302
h.stark@pharmchem.uni-frankfurt.de
Web page

Italy

Co-Leader

Prof Madeleine Ennis

Centre for Infection and Immunity
Room 03/24, Health Sciences Building,
School of Medicine, Dentistry and Biomedical Sciences
Queens University Belfast
97 Lisburn Road
Belfast, BT9 7BL
Northern Ireland

+0044 2890 972672

m.ennis@qub.ac.uk

Web page

Set the standards for better strategies on the potential pharmacological interventions in H4R systems.
The H4R as a target for the treatment of chronic inflammatory diseases, allergy and cancer. Comparison with current treatment approaches.
Evaluation of existing clinical trials and potential of H4R ligands to enter clinical trials.
Economic consequences of any novel therapeutic intervention.

contact info: Paul Chazot | Abdel Ennaceur
Webmaster: A Ennaceur
copyright: Histamine Research: Cost Action BM0806
updated: October 15, 2011